PRT-SCA2

N/A

Report date: 2025/03/26 15:47:42
NME

Base Information

Drug NamePRT-SCA2
Drug Alias NamePRT-SCA2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProbable global transcription activator SNF2L2 degraders
TargetsProbable global transcription activator SNF2L2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrelude Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrelude Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A